Multicare Institute for Research and Innovation — Spokane, Washington

Multicare Institute for Research and Innovation is a clinical research site located in Spokane, Washington, United States 99204.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Multicare Institute for Research and Innovation has participated in 4 clinical trials.

Therapeutic areas: Solid Tumor, Unresectable or Metastatic Melanoma, Leukemia, Myeloid, Acute.

Sponsors: CytomX Therapeutics, Delta-Fly Pharma, Inc., Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Multicare Institute for Research and Innovation?

Multicare Institute for Research and Innovation has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Multicare Institute for Research and Innovation conducted?

Multicare Institute for Research and Innovation has 4 clinical trials on record. Their work covers Solid Tumor, Unresectable or Metastatic Melanoma, Leukemia, Myeloid, Acute.

Is Multicare Institute for Research and Innovation accredited by Crixeo Health?

Multicare Institute for Research and Innovation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Multicare Institute for Research and Innovation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.